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The family Picornaviridae consists of a large group of plus-strand RNA viruses that share a similar genome
organization. The nomenclature of the picornavirus proteins is based on their position in the viral RNA
genome but does not necessarily imply a conserved function of proteins of different genera. The enterovirus 2B
protein is a small hydrophobic protein that, upon individual expression, is localized to the endoplasmic
reticulum (ER) and the Golgi complex, reduces ER and Golgi complex Ca2 levels, most likely by forming
transmembrane pores, and inhibits protein trafficking through the Golgi complex. At present, little is known
about the function of the other picornavirus 2B proteins. Here we show that rhinovirus 2B, which is phylo-
genetically closely related to enterovirus 2B, shows a similar subcellular localization and function to those of
enterovirus 2B. In contrast, 2B proteins of hepatitis A virus, foot-and-mouth disease virus, and encephalo-
myocarditis virus, all of which are more distantly related to enteroviruses, show a different localization and
have little, if any, effects on Ca2 homeostasis and intracellular protein trafficking. Our data suggest that the
2B proteins of enterovirus and rhinovirus share the same function in virus replication, while the other
picornavirus 2B proteins support the viral life cycle in a different manner. Moreover, we show that an
enterovirus 2B protein that is retained in the ER is unable to modify Ca2 homeostasis and inhibit protein
trafficking, demonstrating the importance of Golgi complex localization for its functioning.
The family Picornaviridae is a group of small, nonenveloped
cytolytic viruses that include a number of important human
and animal pathogens. The picornavirus family consists of nine
genera, including enterovirus (e.g., coxsackievirus [CBV] and
poliovirus [PV]), rhinovirus (e.g., human rhinovirus [HRV]),
cardiovirus (e.g., encephalomyocarditis virus [EMCV]), aph-
thovirus (e.g., foot-and-mouth disease virus [FMDV]), hepa-
tovirus (hepatitis A virus [HAV]), teschovirus (e.g., porcine
teschovirus), erbovirus (e.g., equine rhinitis B virus), parecho-
virus (e.g., parechovirus 2), and kobuvirus (e.g., aichivirus). In
addition, the picornavirus family contains a number of unas-
signed viruses. All picornaviruses have a similar genome orga-
nization. The viral genome typically consists of a positive-
stranded RNA molecule of approximately 7,500 to 8,000
nucleotides that contains one single large open reading frame
preceded by a long 5-untranslated region and followed by a
much smaller 3-untranslated region and a genetically encoded
poly(A) tail. A small viral protein, VPg, is covalently linked to
the 5 end of the viral genome. Translation of the RNA ge-
nome yields a polyprotein of approximately 2,200 amino acids
(aa) that is divided into the P1, P2, and P3 regions. The
polyprotein is processed by virus-encoded proteases to gener-
ate the individual structural and nonstructural proteins. Pro-
cessing of the P1 region yields the structural capsid proteins 1A
(VP4), 1B (VP2), 1C (VP3), and 1D (VP1), whereas process-
ing of the P2 and P3 regions yields the nonstructural replica-
tion proteins 2A, 2B, 2C, 3A, 3B (VPg), 3C, and 3D as well as
cleavage intermediates (2BC, 3AB, and 3CD) that are rela-
tively stable and may serve other functions from those of their
individual constituents. It should be emphasized that the no-
menclature of the picornavirus proteins is based on their po-
sition in the viral RNA genome (1A to 3D from the 5 to the
3 end) and does not necessarily imply a conservation of func-
tion between the different genera. The functions of the non-
structural picornavirus proteins have been investigated by anal-
ysis of well-defined mutants, by expression in bacteria and
eukaryotic cells, and by enzymatic assays in vitro. Multiple
functions have been attributed to the mature viral proteins and
the cleavage intermediates, but their exact role in the picorna-
viral replication cycle is still not fully understood (reviewed in
references 22, 28, and 42).
Little is known about the function of the picornavirus 2B
proteins. Most of our current understanding of 2B stems from
studies of enteroviruses. In enterovirus-infected cells, 2B is
present both as a mature protein and as part of the 2BC
protein, a relatively stable precursor protein that is involved in
cytosolic accumulation of the secretory pathway-derived mem-
brane vesicles, where viral replication takes place (4, 31, 35).
Studies of both PV and CBV indicate that 2B plays an impor-
tant role in the modification of intracellular membrane struc-
tures and functions. The 2B protein is a small hydrophobic
membrane protein that localizes at endoplasmic reticulum
(ER) and Golgi complex membranes (4, 15, 33). Increasing
evidence indicates that 2B forms homomultimers that build
pores in ER and Golgi complex membranes (1, 11, 12–14, 41),
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thereby reducing the levels of Ca2 and H in the lumens of
these organelles in infected cells (8, 14, 39). Individual expres-
sion of 2B furthermore results in inhibition of protein traffick-
ing through the Golgi complex (14, 17). It is unknown whether
these activities represent different functions of 2B or whether
the one activity is the consequence of the other. The observa-
tion that 2B mutants that are impaired in increasing the efflux
of ions from the ER and Golgi complex are also impaired in
inhibiting protein trafficking suggests that these activities are
somehow connected (8, 14). The relevance of these 2B activ-
ities for the viral life cycle is still poorly understood. Mutations
that interfere with the ability of 2B to disturb ER and Golgi
complex ion homeostasis and/or to inhibit membrane traffick-
ing cause early defects in viral RNA replication (9, 40). These
2B functions may be required for the activity of the precursor
2BC to accumulate membranous replication vesicles, but other
possibilities cannot be excluded.
In this study, we investigated whether the structural and
functional aspects of the enterovirus 2B protein are conserved
among other members of the picornavirus family. To this end,
the phylogenetic relationships and degree of conservation be-
tween the 2B proteins of CBV, PV, rhinovirus, hepatovirus,
aphthovirus, and cardiovirus were defined. In addition, subcel-
lular localization and possible effects on organelle Ca2 ho-
meostasis and intracellular protein trafficking were investi-
gated. Finally, the importance of the subcellular localization of
enterovirus 2B for its functions was studied.
MATERIALS AND METHODS
Cells and medium. Buffalo green monkey (BGM) cells were grown in minimal
essential medium (Gibco) supplemented with 10% fetal bovine serum, 100 units
penicillin per ml, and 25 g streptomycin per ml. Cells were grown at 37°C in a
5% CO2 incubator.
Antisera. Rabbit polyclonal anti-enhanced green fluorescent protein (anti-
EGFP) was described previously (15). Mouse monoclonal anti-c-myc (clone
9E10) and anti-Flag M2 antisera were obtained from Sigma-Aldrich. Rabbit
polyclonal anti-calreticulin was obtained from Affinity Bioreagents, Inc. Fluores-
cein isothiocyanate-conjugated goat anti-rabbit polyclonal antibody, Texas Red-
conjugated goat anti-mouse polyclonal antibody, and Texas Red-conjugated goat
anti-rabbit polyclonal antibody were obtained from Jackson ImmunoResearch
Laboratories.
Plasmids. pVSV-G(ts045)-GFP (37) was a kind gift from P. Keller and K.
Simons, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden,
Germany. The expression constructs pER-AEQ (30), pGolgi-AEQ (27), p2B-
EGFP, 2B-EGFP-AAAA, 2B-EGFP-KKAA, and p2B-myc p2B-I64S/V66S-
EGFP for CBV3 have been described previously (12, 15). For the construction of
p2B-EGFP and p2B-myc plasmids for the other picornavirus 2B proteins, the 2B
coding sequences were amplified and cloned into the p2B-EGFP and p2B-myc
constructs, from which the CBV3 2B region was removed using SalI and BamHI
restriction sites. The forward primers contained the SalI restriction site (italics)
and a start codon preceded by a Kozak sequence (underlined). The reverse
primers contained a BamHI restriction site (italics). The PV1 2B protein was
amplified using the cDNA clone pXpA (29) and primers p374-11 (5-GGGGG
GGTCGACGCCACCATGGGCATCACCAATTACATAGAG-3; nucleotide
[nt] 3833) and p374-12 (5-CCCCCCGGATCCTGCTTGATGACATAAGGTA
T-3; nt 4123). The HRV14 2B protein was amplified using the cDNA clone
pWR3.26 (21) and primers p374-1 (5-TGGGACAGTGTCGACGCCACCATG
GGGCTGAGTGATTACATCACAGGT-3; nt 3635) and p374-2 (5-GATCC
AGCTGGATCCTTGTCTTTCAATGTAAGGCAC-3; nt 3925). The HAV 2B
protein was amplified using the cDNA clone pHAV/7 (a plasmid containing the
cDNA of the cell culture-adapted HAV175 virus) (10) and primers p374-13
(5-TGGGACAGTGTCGACGCCACCATGGCTAAAATTTCTCTTTTTTAT
ACTGAG-3; nt 3243) and p374-4 (5-GATCCAGCTGGATCCCTGAGTCCT
TAACTCCATCTTCTGGA-3; nt 3995). The FMDV 2B protein was amplified
using the cDNA clone pMR15 (FMDV type 01K) (32) and primers p374-7
(5-TGGGACAGTGTCGACGCCACCATGGGGCCCTTCTTTTTCTCCGAC
GTTAGG-3; nt 3883) and p374-8 (5-GATCCAGCTGGATCCCTGTTTCTC
TGCTCTCTCAAGGTCTTCGGG-3; nt 4344). The 2B protein of EMCV
(strain mengovirus) was amplified using the cDNA clone pM16.1 (18) and prim-
ers p374-5 (5-TGGGACAGTGTCGACGCCACCATGCCTTTCACGTTTAA
ACCAAGACAACGG-3; nt 3966) and p374-6 (5-GATCCAGCTGGATCCCT
GCTGTTGGAAAAGTGAGATCACAGG-3; nt 4415).
Phylogenetic analysis. Alignments were made using the Blosum62 similarity
matrix (20). A phylogenetic tree was constructed using Clustal W (1.81) multiple
sequence alignment software (36).
Subcellular localization. Immunofluorescence was performed as described
previously (15). Briefly, BGM cells were grown on coverslips and transfected with
1 g of picornavirus p2B-myc or with 0.5 g p2B-myc and 0.5 g pEGFP-Golgi
per well, using the FuGENE transfection reagent (Roche) as described previ-
ously (13). Cells were fixed, permeabilized, and stained at 24 h posttransfection.
Primary antibodies were diluted 1:200 (anti-c-Myc) or 1:150 (anti-calreticulin).
Conjugates were diluted 1:200. Cells were analyzed by confocal laser scanning
microscopy (CLSM) (Leica TCS NT; Leica Lasertechnik GmbH, Heidelberg,
Germany).
Intraorganelle calcium homeostasis. ER and Golgi complex Ca2 concentra-
tions were determined using the calcium-sensitive photoprotein aequorin in a
bioluminescence assay as described previously (8). Briefly, BGM cells were
grown on coverslips and transfected with 0.2 g of picornavirus p2B-myc and 0.2
g of either pCI-neo, pCI-ER-AEQ, or pCI-Golgi-AEQ per well, using the
FuGENE transfection reagent (Roche) as described previously (13). At 24 h
posttransfection, aequorins were reconstituted with coelenterazine-N. To effi-
ciently reconstitute the aequorin chimeras and to measure [Ca2] reliably, the
luminal [Ca2] must first be reduced. This was achieved by incubating the cells
in HEPES-Tris medium supplemented with coelenterazine (i.e., the prosthetic
group of aequorin) and ionomycin (a Ca2 ionophore) in the absence of Ca2.
Cells were then transferred to a luminometer and superfused with HEPES-Tris
medium without Ca2 (132 mM NaCl, 4.2 mM KCl, 1 mM MgCl2, 5.5 mM
D-glucose, 10 mM HEPES, 500 M EGTA) at 2 ml per min. Cells were subse-
quently superfused with HEPES-Tris buffer lacking EGTA and containing 1 mM
CaCl2. The recorded aequorin luminescence data were calibrated offline into
[Ca2] values by using a computer algorithm based on the [Ca2] response
curves of mutant aequorins (2).
Inhibition of protein trafficking. Immunofluorescence was performed as de-
scribed above (see “Subcellular localization”). BGM cells were transfected with
0.5 g p2B-myc and 0.5 g pVSV-G-GFP(ts045), incubated at 40°C for 18 h, and
additionally incubated at 32°C for 2 h. Cells were fixed, permeabilized, and
stained. Cells were analyzed by CLSM (Leica TCS NT; Leica Lasertechnik
GmbH, Heidelberg, Germany).
Coimmunoprecipitation. BGM cells were cotransfected with EGFP-tagged
and myc-tagged or Flag-tagged 2B proteins. At 24 h posttransfection, cells were
lysed and EGFP-tagged proteins were precipitated using an anti-EGFP antibody,
as described previously (15). Samples were run in sodium dodecyl sulfate-poly-
acrylamide gels, transferred to nitrocellulose membranes, and immunodetected
with antisera against both EGFP and either c-myc or Flag. Proteins were visu-
alized using a chemiluminescence detection system (Amersham Pharmacia Bio-
tech).
Statistical analysis. Data are presented as mean values  standard deviations.
Differences were tested for significance by means of Student’s t test.
RESULTS
Phylogenetic analysis of picornavirus 2B proteins. A phylo-
genetic analysis of the 2B proteins of enterovirus, rhinovirus,
cardiovirus, aphthovirus, and hepatovirus was performed. The
enterovirus genus can be divided into two subgroups (on the
basis of differences in amino acid sequence), the CBV-like
subgroup and the PV-like subgroup. Both CBV3 2B and PV1
2B were included for a direct comparison of their effects in the
same cell type, using the same expression constructs. The rhi-
novirus genus is divided into groups A and B (34). Sequence
comparison of the 2B proteins of HRV group A and HRV
group B showed that they were very similar (data not shown),
and therefore only HRV14 (HRV group B) was used as a rep-
resentative of the rhinovirus genus. EMCV was used as a repre-
sentative of the cardiovirus genus, FMDV was used as a repre-
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sentative of the aphthovirus genus, and HAV was used as a
representative of the hepatovirus genus.
Phylogenetic analysis showed that the 2B proteins of CBV3
(99 aa), PV1, and HRV14 (both 97 aa) are closely related (Fig.
1A). The 2B proteins of both PV1 and HRV14 share 51% and
55% identity (71% and 74% similarity), respectively, with
CBV3 2B and 49% identity (71% similarity) with each other
(Fig. 1B). Like CBV3 2B, both PV1 2B and HRV14 2B contain
two hydrophobic regions (referred to as HR1 and HR2) (Fig.
1C), of which the first is predicted to form a cationic amphi-
pathic -helix, typical of membrane-lytic polypeptides (Fig.
1D), separated by a short hydrophilic sequence (38).
The 2B proteins of EMCV, FMDV, and HAV share little, if
any, relationship (20% sequence identity) to the enterovirus
and rhinovirus 2B proteins (Fig. 1A and B). They also share
little sequence identity with each other or with the 2B proteins
FIG. 1. Genetic analysis of picornavirus 2B proteins. (A) Phylogenetic tree of the 2B proteins constructed with Clustal W software. The
Blosum62 similarity matrix was used to perform sequence alignment analysis. The phylogenetic tree shows that the 2B proteins of CBV3, PV1, and
HRV14 are grouped together, whereas the 2B proteins of viruses from other genera are more distantly related. (B) Identity matrix for 2B proteins.
Identity was calculated using the Blosum62 similarity matrix. (C) Pairwise alignment of CBV3, PV1, and HRV14 2B proteins. All three proteins
contain two hydrophobic regions (HR1 and HR2) spaced by a 5-aa hydrophilic sequence. Dots represent residues that are identical to those in
CBV3 2B. Dashes indicate gaps in the alignment. (D) Top view of the amphipathic -helices of the first hydrophobic region of CBV3, PV1, and
HRV14 2B proteins. Note that all three proteins contain a hydrophobic backbone and a hydrophilic face that contains three cationic residues.
Hydrophobic residues are boxed. CBV3, coxsackievirus B3; HRV14, human rhinovirus 14; PV1, poliovirus 1; FMDV, foot-and-mouth disease
virus; EMCV, encephalomyocarditis virus; HpaV2, human parechovirus 2; PTV, porcine teschovirus; ERBV, equine rhinitis B virus; HAV,
hepatitis A virus.
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of aichivirus (kobuvirus), human parechovirus 2 (parechovi-
rus), porcine teschovirus (teschovirus), and equine rhinitis B
virus (erbovirus) (Fig. 1A and B). The EMCV, FMDV, and
HAV 2B proteins are larger than the enterovirus and rhinovi-
rus 2B proteins (EMCV 2B, 151 aa; FMDV 2B, 155 aa; and
HAV 2B, 251 aa). They contain one or more hydrophobic
regions, but none of them contains a cationic amphipathic
-helix typical of the group of membrane-lytic polypeptides, as
can be found in all enterovirus and rhinovirus 2B proteins.
Subcellular localization of picornavirus 2B proteins. CBV3
2B is present predominantly in the Golgi complex upon indi-
vidual expression (15). Here we determined the subcellular
localization of the other picornavirus 2B proteins. To this end,
the coding regions of the picornavirus 2B proteins were am-
plified and cloned into a eukaryotic expression vector that
drives the expression of proteins carrying a c-myc tag at the C
terminus. The experiments were performed with BGM kidney
cells because all viruses used in this study are able to replicate
in kidney cell lines, indicating that the 2B proteins have the
ability to fulfill their function(s) in these cells (5, 7, 25, 26).
BGM cells were transfected with the expression constructs,
and the subcellular distribution of the 2B proteins was com-
pared with that of markers for the Golgi complex (EGFP-
Golgi) and the ER (calreticulin), as described previously (15).
Like CBV3 2B, PV1 2B colocalized predominantly with the
EGFP-Golgi protein (Fig. 2A and B). The closely related
HRV14 2B showed a subcellular distribution that was similar
to that of enterovirus 2B and also predominantly colocalized
with the Golgi marker (Fig. 2C). The more distantly related
HAV, EMCV, and FMDV 2B proteins showed different sub-
cellular localizations. HAV 2B stained in a reticular pattern
that included the nuclear envelope and was largely identical to
staining of calreticulin (Fig. 2E), indicating that HAV 2B is
localized to the ER. HAV 2B was virtually absent from the
Golgi complex (Fig. 2D), but in some highly expressing cells,
some colocalization of HAV 2B with EGFP-Golgi was ob-
FIG. 2. Subcellular localization of picornavirus 2B proteins. (A to D, F, and H) BGM cells were cotransfected with EGFP-Golgi and the
indicated 2B-myc constructs, fixed at 24 h posttransfection, and stained with anti-c-myc antiserum. (E, G, and I) BGM cells were transfected with
the indicated 2B-myc constructs, fixed at 24 h posttransfection, and stained with anti-c-myc and anti-calreticulin antisera. Cells were analyzed by
CLSM. The 2B-myc proteins of CBV3 (A), PV1 (B), and HRV14 (C) colocalized with the Golgi marker. HAV 2B did not colocalize with the Golgi
marker (D) but was colocalized predominantly with the ER marker (E). FMDV 2B (F and G) and EMCV 2B (H and I) did not colocalize with
the Golgi and ER markers. Bars  10 m.
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served (not shown). In lowly and moderately expressing cells,
FMDV and EMCV 2B proteins showed no colocalization with
either calreticulin or EGFP-Golgi (Fig. 2F to I), indicating that
these proteins are not present in the ER or the Golgi complex.
In cells expressing high levels of FMDV 2B, staining and mor-
phology of both the ER and the Golgi complex were often
affected, yet there was still no obvious colocalization of 2B and
the ER or Golgi marker (not shown).
Intraorganelle calcium concentrations in 2B-expressing
cells. We previously demonstrated that expression of CBV3 2B
reduced ER and Golgi complex Ca2 levels (8, 14). Here we
analyzed whether the other picornavirus 2B proteins also have
the ability to modify ER and Golgi complex Ca2 homeostasis,
using the Ca2-sensitive photoprotein aequorin as described
previously (8). To this end, BGM cells were cotransfected with
the different 2B-myc constructs and either pCI-ER-AEQ, pCI-
Golgi-AEQ, or the empty pCI expression vector. Ca2 mea-
surements were performed at 24 h posttransfection. Offline
calibration of the aequorin bioluminescence data into [Ca2]
values revealed that expression of CBV3, PV1, or HRV14 2B
resulted in a significant decrease in intraluminal ER and Golgi
complex [Ca2] (Fig. 3). HAV 2B expression did not alter ER
or Golgi complex [Ca2], while EMCV 2B significantly de-
creased ER [Ca2] but not Golgi complex [Ca2] (Fig. 3).
Unfortunately, we were unable to reliably measure the ER and
Golgi complex [Ca2] in FMDV 2B-expressing cells. Immuno-
fluorescence analysis showed that the aequorin probes were
aberrantly localized in cells expressing high levels of FMDV 2B
(not shown). Since the aequorin probes measure the average
ER or Golgi complex [Ca2] of the total population of 2B-
expressing cells, false results could be obtained due to mistar-
geting of the aequorin probes to low-[Ca2] compartments in
cells expressing high levels of FMDV 2B.
Effects of picornavirus 2B proteins on protein trafficking
through the secretory pathway. Next, we investigated whether
the other picornavirus 2B proteins are able to interfere with
protein trafficking through the secretory pathway. We used a
temperature-sensitive mutant of the envelope glycoprotein of
vesicular stomatitis virus (VSV-G-ts045; hereafter referred to
as VSV-G) fused to fluorescent EGFP (VSV-G–GFP) to study
protein trafficking. The temperature-sensitive VSV-G–GFP
mutant is misfolded at 40°C, resulting in its accumulation in
the ER. Upon shifting of the temperature to 32°C, the protein
FIG. 3. Analysis of ER and Golgi complex stored Ca2 in cells expressing picornavirus 2B proteins. BGM cells were cotransfected with
ER-targeted (A) or Golgi complex-targeted (B) aequorin and the indicated 2B-myc constructs. At 24 h posttransfection, ER and Golgi complex
stores were depleted of Ca2 and the aequorins were reconstituted with coelenterazine. Cells were perfused with HT medium without Ca2 and
subsequently with HT medium supplemented with 1 mM free Ca2. The recorded aequorin luminescence data were calibrated offline into [Ca2]
values. Representative traces are shown for CBV3 2B. (A) ER Ca2 levels were reduced in cells expressing CBV3, PV1, HRV14, or EMCV 2B
but not in cells expressing HAV 2B. (B) Golgi complex Ca2 levels were reduced in cells expressing CBV3, PV1, or HRV14 2B but not in cells
expressing HAV or EMCV 2B.
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is refolded correctly and transported via the secretory pathway,
resulting in its exposure on the plasma membrane (16).
BGM cells were cotransfected with expression constructs for
VSV-G–GFP and the picornavirus 2B-myc proteins. Cells were
incubated at 40°C for 18 h to accumulate VSV-G–GFP in the
ER (Fig. 4A, left panel) and subsequently incubated at 32°C
for 2 h to allow VSV-G–GFP transport out of the ER (Fig. 4A,
right panel). Cells were fixed, stained with the anti-c-myc an-
tiserum, and processed for CLSM analysis. Similar to CBV3
2B, the 2B proteins of PV1 and HRV14 efficiently inhibited
protein trafficking through the Golgi complex (Fig. 4B to D).
In cells expressing these 2B proteins, VSV-G–GFP accumu-
lated in the juxtanuclear Golgi region, where it colocalized
with the respective 2B proteins. This demonstrates that the
ability of 2B to inhibit protein trafficking through the Golgi
complex is conserved among these three closely related viruses.
In contrast, expression of HAV, FMDV, or EMCV 2B did not
result in the inhibition of protein trafficking. VSV-G–GFP was
predominantly localized on the plasma membrane and showed
no colocalization with these 2B proteins (Fig. 4E to G).
Is Golgi complex localization of 2B required for alterations
in calcium homeostasis and protein trafficking? Thus far, we
have demonstrated that the 2B proteins of PV1, CBV3, and
HRV14 are closely related and that these proteins localize
predominantly to the Golgi complex, reduce ER and Golgi
complex Ca2 levels, and inhibit protein trafficking. We asked
ourselves whether the Golgi complex localization of enterovi-
rus and rhinovirus 2B proteins is required for their ability to
modify Ca2 homeostasis and to inhibit protein trafficking or if
2B can also exert these functions from the ER. To this end, we
made use of wild-type CBV3 2B-EGFP carrying a C-terminal
KKAA dilysine motif (2B-EGFP-KKAA), which acts as an ER
retention signal in mammalian cells (15). Cells were cotrans-
fected with expression constructs for ER-targeted or Golgi
complex-targeted aequorins and either 2B-EGFP-KKAA or
the control plasmid EGFP or 2B-EGFP-AAAA, and the ER
and Golgi complex Ca2 concentrations were determined as
described above. Figure 5A and B show that expression of
2B-EGFP-KKAA had no effect on the filling state of the ER
and Golgi complex Ca2 stores. The finding that 2B-EGFP-
AAAA expression reduced both ER and Golgi complex Ca2
levels demonstrates that the presence of a C-terminal tag does
not inhibit 2B-EGFP function. Consistently, the ER-retained
Flag-2B-KKAA did not alter VSV-G–GFP trafficking, while
Flag-2B-AAAA expression resulted in the accumulation of
VSV-G–GFP in the juxtanuclear Golgi area, where it colocal-
ized with 2B-AAAA (Fig. 5C). The possibility that the func-
tions of ER-retained 2B-EGFP-KKAA are impaired because
FIG. 4. Analysis of protein trafficking in cells expressing picornavirus 2B proteins. BGM cells were transfected with the VSV-G–GFP construct
(A) or cotransfected with VSV-G–GFP and the picornavirus 2B-myc constructs (B to G). Cells were incubated at 40°C for 18 h to accumulate
VSV-G–GFP in the ER and subsequently incubated at 32°C for 2 h (B to G). Cells were fixed, stained with the anti-c-myc antiserum, and processed
for CLSM analysis. (A) Accumulation of VSV-G–GFP in the ER upon incubation at 40°C (left) and on the plasma membrane upon additional
incubation at 32°C (right). VSV-G–GFP accumulated in the Golgi complex upon incubation with CBV3 2B (B), PV1 2B (C), and HRV14 2B (D).
VSV-G–GFP was exposed on the plasma membrane in cells expressing HAV 2B (E), FMDV 2B (F), or EMCV 2B (G). Bars  10 m.
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the KKAA tag somehow interferes with 2B homomultimeriza-
tion, which is a prerequisite for 2B to exert its functions, was
considered (8, 12, 14, 15). To investigate multimerization, co-
immunoprecipitation experiments were set up. First, multim-
erization of wild-type 2B was tested using this method. BGM
cells coexpressing wild-type 2B-EGFP and 2B-myc were lysed
at 24 h posttransfection, and the EGFP-tagged proteins were
precipitated using an anti-EGFP antibody as described previ-
ously (15). Western blot analysis showed that 2B-myc was
efficiently coimmunoprecipitated with 2B-EGFP but not with
EGFP alone or the multimerization-deficient mutant 2B-I64S/
V66S-EGFP (13) (Fig. 5D). To investigate homomultimeriza-
tion of 2B-KKAA, BGM cells were cotransfected with Flag-
2B-KKAA and 2B-EGFP-KKAA expression constructs.
Figure 5D shows that Flag-2B-EGFP was coimmunoprecipi-
tated with 2B-EGFP-KKAA but not with EGFP, indicating
that the ability of 2B to homomultimerize was not affected by
the presence of the KKAA tag. All proteins were efficiently
expressed, excluding the possibility that differences in copre-
cipitation were due to different expression levels.
Together, these results further emphasize the importance of
the Golgi complex localization of enterovirus 2B, and most
likely also of rhinovirus 2B, for its activities in the host cell.
DISCUSSION
This study was performed to gain more insight into the
phylogenetic conservation of the structure and function of
the picornavirus 2B proteins. Our results demonstrate that the
structural and functional properties of enterovirus 2B (repre-
sented in this study by CBV3 and PV1 2B) and rhinovirus 2B
(represented by HRV14 2B) are strongly conserved. Phyloge-
netic analysis revealed that CBV3, PV1, and HRV14 2B pro-
teins are closely related and share approximately 50% identity
α α
αα
FIG. 5. Importance of Golgi complex localization for the abilities of CBV3 2B to modify Ca2 homeostasis and to inhibit protein trafficking.
(A and B) ER and Golgi complex Ca2 levels. BGM cells coexpressing ER-targeted (A) or Golgi complex-targeted (B) aequorin and the indicated
2B or control constructs were analyzed at 24 h posttransfection as described in the legend to Fig. 3. ER and Golgi complex Ca2 levels were
unchanged in cells expressing ER-localized 2B-EGFP-KKAA or the EGFP control, while 2B-EGFP expression decreased ER and Golgi complex
Ca2 levels. (C) Protein trafficking. BGM cells coexpressing VSV-G–GFP and either Flag-2B-KKAA or Flag-2B-AAAA were analyzed for
VSV-G–GFP trafficking as described in the legend to Fig. 4. Flag-2B-KKAA did not alter VSV-G–GFP trafficking, while expression of control
Flag-2B-AAAA resulted in the accumulation of VSV-G–GFP in the juxtanuclear Golgi area, where it colocalized with Flag-2B-AAA. Bars  10
m. (D) Homomultimerization. BGM cells (co)expressing the indicated proteins were lysed at 24 h posttransfection, and lysates were subjected
to immunoprecipitation using an anti-EGFP antibody. Coimmunoprecipitation of 2B-myc with 2B-EGFP is demonstrated, while 2B-myc could not
be precipitated from lysates of cells expressing 2B-myc alone or coexpressing 2B-myc and EGFP or 2B-I64S/V66S-EGFP. Flag-2B-KKAA was
coimmunoprecipitated with 2B-EGFP-KKAA but not with EGFP. Analysis of the lysates that were used as input for the coimmunoprecipitation
experiments demonstrated that all proteins were properly expressed.
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and 70% similarity. Despite differences in amino acid se-
quence, CBV3, PV1, and HRV14 2B proteins share remark-
able structural similarities. These proteins are similar in length
(97 to 99 aa) and contain two hydrophobic regions, the first of
which is predicted to form a cationic amphipathic -helix typ-
ical for the group of lytic polypeptides. The amphipathic -he-
lices of these 2B proteins all contain three lysine residues in the
(small) hydrophilic face of the helix. CBV3 2B is present at ER
and Golgi complex membranes (15) and is responsible for the
release of Ca2 and H from these organelles, most likely by
forming membrane-integral pores (8, 14). Moreover, CBV3 2B
has been shown to inhibit protein trafficking through the Golgi
complex and to increase hygromycin B entry (14, 40). Here we
demonstrate that PV1 and HRV14 2B proteins also localize to
the Golgi complex, reduce ER and Golgi complex Ca2 levels,
and inhibit VSV-G trafficking through the Golgi complex,
whereas the more distantly related HAV, FMDV, and EMCV
2B proteins behave differently.
The 2B protein of HAV (a member of the hepatoviruses)
shares little or no sequence and structural homology with the
other picornavirus 2B proteins. HAV 2B had little, if any,
effect on ER and Golgi complex Ca2 homeostasis. Moreover,
it did not inhibit protein trafficking through the secretory path-
way. The latter finding is consistent with the hypothesis that
HAV uses the secretory pathway to leave the cell, as virus
release of the cell culture-adapted HAV strain from polarized
epithelial cells was shown to be sensitive to trafficking-inhib-
iting drugs (6). Analysis of the subcellular localization of HAV
2B demonstrated that it localized predominantly in the ER and
was absent from the Golgi complex. Immunoelectron micros-
copy analysis of the subcellular localization of HAV 2B in
transfected cells (FRhK-4 and HeLa) demonstrated that the
protein was present almost exclusively in a tubular-vesicular
network, whose origin (i.e., the presence of organelle-specific
markers) was not investigated (19). Our finding that HAV 2B
largely colocalizes with a marker for the ER suggests that the
tubular-vesicular structures may be derived, at least partly,
from the ER.
The 2B proteins of FMDV and EMCV (members of the
aphthoviruses and cardioviruses, respectively) are not related
to any of the other picornavirus 2B proteins or to each other
and showed a different localization from those of the other 2B
proteins. In lowly to moderately expressing cells, both FMDV
2B and EMCV 2B appeared to be absent from the ER and the
Golgi complex. Instead, they showed a punctate localization
pattern in the cytosol, whose exact nature remains to be estab-
lished. The localization of these proteins in highly expressing
cells is less clear, and we cannot exclude the possibility that in
these cells there is some degree of colocalization with ER
markers, as seen for FMDV 2B (23, 24). Although EMCV 2B
does not show a clear ER localization and lacks an amphi-
pathic helix that is typical for the group of lytic polypeptides,
expression of this protein was found to reduce the ER Ca2
level (but not the Golgi complex Ca2 level). The mechanism
underlying this reduction remains to be established. Unfortu-
nately, possible effects of FMDV 2B on ER and Golgi complex
Ca2 levels could not be investigated reliably because overex-
pression of this protein interfered with the correct localization
of the calcium-sensitive aequorin probes. Neither FMDV 2B
nor EMCV 2B interfered with protein trafficking through the
secretory pathway. We are not aware of studies addressing
protein trafficking in EMCV-infected cells, but early secretory
pathway transport in FMDV-infected cells is inhibited (23). In
agreement with our results, Moffat and coworkers recently
showed that FMDV 2B alone does not inhibit transport but
that coexpression of 2B and 2C or expression of the 2BC
precursor protein is required for this effect (24).
Expression of the 2B proteins of both PV1 and CVB3 was
previously shown to result in increased entry of hygromycin B,
a drug that under normal conditions enters cells poorly (12, 15,
17, 40). The mechanism by which these enterovirus 2B proteins
increase hygromycin B entry is still unknown. A possible ex-
planation was recently provided by Cornell et al., who showed
that endocytosis is upregulated upon individual expression of
CVB3 2B and 2BC (10). There are strong indications that this
effect is directly linked to the abilities of 2B to reduce ER and
Golgi complex Ca2 levels and to inhibit protein transport
because mutations that disrupt these abilities also impair the
ability of 2B to increase hygromycin B entry (8, 12, 14, 15, 40).
Consistently, we found that expression of HRV 2B caused a
similar strong increase in hygromycin B entry to that of CBV
2B, whereas expression of HAV, FMDV, and EMCV 2B pro-
teins had little effect (data not shown).
To investigate the importance of the Golgi complex local-
ization of the enterovirus 2B protein for its function(s), we
tested a (wild-type) CBV3 2B protein that is retained in the ER
by virtue of an ER retention signal. Through this approach,
evidence was obtained that the ability of 2B to reduce ER and
Golgi complex Ca2 levels as well as to inhibit protein traf-
ficking critically depends on its Golgi complex localization. The
observation that this ER-retained protein was unable to reduce
the ER Ca2 level was surprising. Coimmunoprecipitation ex-
periments showed that this was not due to impaired formation
of multimers in the ER. The finding that formation of 2B
multimers in the ER is not sufficient to trigger the efflux of
Ca2 from this store indicates that 2B multimerization is not
sufficient for pore formation. A possible explanation is that the
mode of membrane interaction of 2B in the ER differs from
that in the Golgi complex, possibly due to differences in lipid
composition of these organelles that may affect the architec-
ture of 2B multimers. Previously, we showed that the ER-
retained CVB 2B also failed to increase the entry of hygromy-
cin B (15). Although its exact function in the viral life cycle
remains to be elucidated, the observations reported here point
to the Golgi complex as the major target organelle of the
enterovirus/rhinovirus 2B proteins, from where they exert (part
of) their function(s).
Taken together, our results have demonstrated that the abil-
ities of the enterovirus 2B protein to reduce ER and Golgi
complex stored Ca2 and to inhibit protein trafficking through
the Golgi complex are conserved in the closely related rhino-
virus 2B protein but not in the more distantly related 2B
proteins of HAV, FMDV, and EMCV. We conclude that the
2B proteins of enterovirus and rhinovirus are closely related
and most likely exhibit the same function in the viral life cycle.
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